• Plandai Biotechnology, Inc. (PLPL.OB) Creates New Jobs and Commences Farming Operations at Senteeko Tea Estate More...

• Hyperion Therapeutics Prices IPO at $10.00, Below the Range Expected More...

• Mycell Technologies LLC Announces $10 Million Institutional Financing More...

• Navidea Biopharmaceuticals (NEOP) Announces $50 Million Credit Facility With Platinum-Montaur Life Sciences More...

• BioTime (BTX) Subsidiary LifeMap Sciences, Inc. Announces Financing of Up to $3 Million From Share Exchange Agreement More...

• Nuvo Research Inc. (NRI.TO) Receives E4.4 Million Additional Funding to Develop WF10 More...

• Lupin Ltd. (LUPN.BO) Plans to Acquire US Brands More...

• iBio, Inc. (IBIO) and GE Healthcare Form New Global Alliance More...

• Proteostasis Therapeutics, Inc. Announces Expansion of Collaboration With The Scripps Research Institute to Broaden Cystic Fibrosis Program More...

• Histogenics Corporation Selects ImageIQ to Provide Imaging Analysis for Phase 3 Clinical Trial More...

• Omnicare, Inc. (OCR) Could Have New CEO by End of September More...

• GlaxoSmithKline (GSK)'s R&D is Delivering, But the Street's Not Buying More...

• Roche (RHHBY) Profit Down on Site Closure Costs More...

• AstraZeneca PLC (AZN) Sales Hit Hard by Generic Competition More...

• Sanofi (France) (SAN.PA) Earnings Rise on Lower Restructuring Costs More...

• Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) to Report 2nd Quarter Financial Results on August 2, 2012; Conference Call to Follow More...

• Genzyme Corporation (GENZ) Ordered to Fork Over $50 Million to Settle Patent Fight More...

• Merck & Co., Inc. (MRK) Uncovers Clues that Could Lead to AIDS Cure More...

• American Academy of Neurology Publishes Results From Pivotal Study of Eisai Inc. (ESALF.PK)'s Perampanel More...

• Maxwell Biotech Venture Fund's Portfolio Company, Infectex, Receives Russian Regulator's Approval to Conduct Pivotal Clinical Trial for Sequella, Inc.'s Antibiotic, SQ109, for Tuberculosis More...

• Onyx Pharmaceuticals, Inc. (ONXX) Announces Kyprolis&#0153 Study Published in the Medical Journal Blood More...

• Apogenix: APG101 Exceeds Expectations With Controlled Phase II Clinical Trial in Treatment of Recurrent Glioblastoma More...

• Amarin Corporation PLC (AMRN) FDA Approval Likely Today More...

• pSivida Corp (PSDV) Announces Germany Grants ILUVIEN® Marketing Authorization for the Treatment of Chronic Diabetic Macular Edema More...

• How Our Brains See Men as People and Women as Body Parts, University of Nebraska Study More...

• High Blood Sugar, Obesity Increase Risk for Surgical Site Infection, Journal of Bone and Joint Surgery Reveals More...

• Hope for More Effective TB Treatment, Stellenbosch University Study More...

• Stress May Cause Women's Brains to Age Prematurely, University of California, Berkeley (CAL) Study More...

• Research Ban for Surgeons After Probiotic Experiment, University of California, Davis (UCD) Reveals More...

• Research & Diagnostic Antibodies Receives Notice of Allowance for Second Key Sepsis Diagnostic Patent in Japan More...

• Advanced Cell Technology Issued Broad Patent for Human RPE Cells Derived From All Types of Pluripotent Stem Cells More...

• Novartis AG (NVS) Resumes Production of Excedrin More...

• UK Authority Backs Down in Novartis AG (NVS) Eye Drug Dispute More...